10-hydroxycamptothecin has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL | 1 |
| Chen, P; Jian, S; Li, F; Li, H; Li, J; Liang, S; Liu, Z; Sun, X; Zeng, Y; Zhang, P; Zhang, Q | 1 |
| Fang, Y; Hu, W; Lou, C; Zhang, C | 1 |
3 other study(ies) available for 10-hydroxycamptothecin and B16 Melanoma
| Article | Year |
|---|---|
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1991 |
Drug-Bearing Peptide-Based Nanospheres for the Inhibition of Metastasis and Growth of Cancer.
Topics: A549 Cells; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; HeLa Cells; Hep G2 Cells; Humans; Melanoma, Experimental; Nanospheres; Nanostructures; Neoplasms; Peptides; Small Molecule Libraries | 2020 |
Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Female; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 2011 |